Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$418M |
| 2 |
GE Vernova
GEV
|
+$377M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$328M |
| 4 |
CrowdStrike
CRWD
|
+$199M |
| 5 |
PACCAR
PCAR
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$597M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$541M |
| 3 |
GE Aerospace
GE
|
+$418M |
| 4 |
Broadcom
AVGO
|
+$333M |
| 5 |
NVIDIA
NVDA
|
+$299M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.63% |
| 2 | Financials | 11.08% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Industrials | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4276
Sypris Solutions
SYPR
$46.9M
| $30.7K | ﹤0.01% |
16,015
-43
| -0.3% | -$68 |
|
4277
Bolt Biotherapeutics
BOLT
$7.67M
| $30.7K | ﹤0.01% |
2,045
-5
| -0.2% | -$99 |
|
4278
Aterian
ATER
$5.22M
| $30.6K | ﹤0.01% |
10,879
-53
| -0.5% | -$132 |
|
|
UBX
4279
DELISTED
Unity Biotechnology
UBX
| $30.4K | ﹤0.01% |
22,549
-30
| -0.1% | -$46 |
|
4280
Smith Micro Software
SMSI
$16M
| $30.1K | ﹤0.01% |
2,725
+103
| +4% | +$1.21K |
|
|
STLN
4281
Starling Oncology, Inc. Common Stock
STLN
$616M
| $29.9K | ﹤0.01% |
64,902
-94
| -0.1% | -$80 |
|
4282
Exagen
XGN
$161M
| $29.7K | ﹤0.01% |
16,307
-63
| -0.4% | -$107 |
|
4283
bioAffinity Technologies
BIAF
$3.08M
| $29.5K | ﹤0.01% |
455
| – | – |
|
|
AKLI
4284
DELISTED
Akili Inc
AKLI
| $28.8K | ﹤0.01% |
66,290
| – | – |
|
4285
Cocrystal Pharma
COCP
$14.9M
| $28.4K | ﹤0.01% |
12,171
-36
| -0.3% | -$70 |
|
4286
Educational Development Corp
EDUC
$11.8M
| $28.1K | ﹤0.01% |
15,182
-368
| -2% | -$766 |
|
|
KORE
4287
DELISTED
KORE Group Holdings
KORE
| $28.1K | ﹤0.01% |
13,249
-18
| -0.1% | -$63 |
|
|
VINC
4288
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $27.8K | ﹤0.01% |
1,715
-1
| -0.1% | -$25 |
|
4289
RAVE Restaurant Group
RAVE
$43.9M
| $27.7K | ﹤0.01% |
13,972
-68
| -0.5% | -$135 |
|
|
CYTH
4290
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
| $27.6K | ﹤0.01% |
21,722
-19
| -0.1% | -$25 |
|
|
NUTX
4291
Nutex Health
NUTX
$1.35B
| $27.1K | ﹤0.01% |
4,563
| – | – |
|
|
LPTV
4292
DELISTED
Loop Media, Inc.
LPTV
| $27.1K | ﹤0.01% |
268,745
-10,727
| -4% | -$2.64K |
|
4293
Beasley Broadcasting Group
BBGI
$39.6M
| $26.8K | ﹤0.01% |
2,040
-43
| -2% | -$601 |
|
4294
Cardio Diagnostics
CDIO
$5.06M
| $26.7K | ﹤0.01% |
1,621
+744
| +85% | +$17.5K |
|
4295
TherapeuticsMD
TXMD
$24M
| $26.5K | ﹤0.01% |
16,457
| – | – |
|
4296
ProQR Therapeutics
PRQR
$255M
| $26.4K | ﹤0.01% |
15,932
-1,488
| -9% | -$2.89K |
|
|
CHRN
4297
ChronoScale Holdings
CHRN
$2.82B
| $26.2K | ﹤0.01% |
1,657
-1
| -0.1% | -$19 |
|
4298
Comstock
LODE
$247M
| $25.7K | ﹤0.01% |
15,648
-16
| -0.1% | -$41 |
|
4299
Quince Therapeutics
QNCX
$30M
| $25.5K | ﹤0.01% |
170
| – | – |
|
|
VIVK
4300
Vivakor
VIVK
$1.05M
| $25.5K | ﹤0.01% |
+3
| New | +$16.1K |
|
Similar funds
Northern Trust's Q2 2024 Portfolio in Review
As of Q2 2024, Northern Trust held 4,534 positions worth $593B, up 2.5% from $579B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Northern Trust's Q2 2024 filing shows 109 new, 1,663 increased, 2,507 reduced and 120 closed positions. Its largest new stake was GE Vernova: 2,379,949 shares worth $408M. The largest sale was Pioneer Natural Resource Co., an estimated $597M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q2 2024 buy was GE Vernova: 2,379,949 shares worth $408M.
- Northern Trust added most to ExxonMobil in Q2 2024, an estimated $418M increase.
- Northern Trust's biggest Q2 2024 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $541M.
- Northern Trust fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $597M.
- Northern Trust's ten largest holdings make up 28% of its $593B portfolio in Q2 2024.
- Northern Trust opened 109 new positions and closed 120 in Q2 2024.
- Northern Trust's portfolio value rose 2.5% quarter-over-quarter to $593B.
Based on Northern Trust's 13F filing for Q2 2024, filed 14 Aug 2024.